https://www.thebodypro.com/category/prep-hiv-pre-exposure-prophylasxis/tag/trans

The Latest

cisgender woman prescription

Evaluating PrEP Uptake and Adherence in Cisgender Women—and What to Do About It

Two researchers discuss their analysis of Philadelphia FIGHT’s HIV pre-exposure prophylaxis (PrEP) program for cisgender women.

Vaccination being filled

Investigational PrEP Injection, Dosed Every Other Month, Holds Up Against Daily PrEP in Phase 3 Study

The long-acting injectable drug cabotegravir proved non-inferior to daily oral TDF/FTC for MSM and transgender women.

data

This Week in HIV Research: There’s No Such Thing as Too Much Data

May 7, 2020: Epidemiological factors among transgender women; revised PrEP indication estimates for MSM; trends in HIV strain similarity between younger and older MSM; current hepatitis C epidemic among British MSM with HIV.

integrase inhibitor

This Week in HIV Research: The Fast-Acting Power of Integrase

April 9, 2020: Rapid efficacy of integrase-based treatment; a potent PrEP ad campaign in Chicago; more frequent STI screening for PrEP users; Ryan White funding fuels critical rural HIV care and services.

Senior woman receives prescription medication from doctor

Should All PrEP Users on Truvada Switch to Descovy? These Leading Docs Say, ‘Not So Fast.’

Many fear the push to put more people on the new brand-name drug before Truvada goes generic this year.

Johanne Morne and Dr. Oni Blackstock

Ending the HIV Epidemic Is a Team Effort. The New York City and State Health Departments Discuss Their Combined Work

Johanne Morne, M.S., and Oni Blackstock, M.D., sat down with TheBody to discuss their successes and their work to close the disparities gap.

long winding road through countryside

This Week in HIV Research: The Long Road to the End

Dec. 12, 2019: A lot of catchup to do before “Ending the HIV Epidemic”; the value of online HIV self-test distribution; viral suppression is about more than basic HIV treatment services; effect of hormone therapy on PrEP levels.

Christina Garcia and Patricia "PJ" Nachman of TIN Rx

To Combat LGBTQ and HIV Stigma, These Two Women Are Reinventing the Pharmacy

For people taking medications for HIV prevention, HIV treatment, STIs, or transgender health care, this couple -- in life and in business -- seeks to revolutionize the pharmacy experience at TIN Rx in San Francisco.

PrEP Posters

Black Women in Atlanta Need More PrEP Access. Researchers and Advocates Are Working to Make This a Reality.

While most pre-exposure prophylaxis (PrEP) campaigns focus on gay and bisexual men, Fulton County Board of Health officials and advocates look for solutions to get PrEP to black women.

Scientist holding slide with blood sample in lab

This Week in HIV Research: U=U Grows Ever Stronger

Oct. 10, 2019: Long-term viral suppression = zero genital tract shedding among women; HIV treatment initiation and sexual risk among MSM; PrEP interest vs. uptake among trans women of color; polypharmacy among people living with HIV.